News and Events

Date August 2021

We have published a really important paper in Biofilm diagnostic !!!!! Our paper is out !!!

Blanco-Cabra, N., López-Martínez, MJ., Arévalo-Jaimes, BV., Martín-Gómez, MT., Samitier, J. and Torrents, E. (2021). A new BiofilmChip device as a personalized solution for testing biofilm antibiotic resistance. npj Biofilms and Microbiomes 7:62.

Date May 2021

An important review paper now is out in a important journal.

Cendra, MdM., Torrents, E. (2021). Pseudomonas aeruginosa biofilms and their partners in crime. Biotechnology Advances. 49:107734

This paper was cited in the Investigación y Ciencia.

Date July 2020

Two new publication about our work on Galleria mellonella

Date July 2020

Nice publication in Virulence !!!

Date June 2020

Two papers with really nice collaborations !!!

Date November 2019

We are closer for Pseudomonas and Staphylococcus co culture !!!!

Two new publications in our laboratory !! Really proud for it .

Date July 2019

We are really happy for our new paper published in ACS Infectious Disease

New antimicrobial compounds to fight infectious diseases !!!!!!

Date 4 February 2019

We published a new papers on drug delivery !!!!!

See our new publication about the development of a new methodology to investigate antimicrobial activity in metallic, plasmonic or highly dense nanoparticles.

Date 23 December 2018

We published three new papers about new antimicrobials.

Press release at the IBEC webpage.

Date 20 December 2017

Why Pseudomonas aeruginosa infection becames chronic ???

Press release at the IBEC webpage.

Date 23 NOVEMBER 2017


Basas,J., Palau, M., Ratia, C., del Pozo, JL., Martín-Gómez, MT., Gomis, X., Torrents, E., Almirante, B and Gavaldà, J. (2017). High-dose daptomycin is effective as an antibiotic-lock therapy in a rabbit model of Staphylococcus epidermidis catheter-related infection. Antimicrob. Agents Chemother. In Press.

Date 18 October 2017


Pseudomonas aeruginosa PAO1 strain is not an ideal bacteria for the screening of new antimicrobial drugs.

Crespo, A., Gavaldà, J., Julián, E., Torrents, E. (2017). A single point mutation in class III ribonucleotide reductase promoter renders Pseudomonas aeruginosa PAO1 inefficient for anaerobic growth and infection. Scientific Reports 7: 13350.

Date 24 August 2016

We are waiting for the new team members in the lab (new PhD students, new PostDoc, new Master students, etc).

Date 10 August 2016


Basas, J., Morer, A., Ratia, C., Martín, MT., del Pozo, JL., Gomis, X., Rojo-Molinero, E., Torrents, E., Almirante, B., Gavaldà, J. (2016). Efficacy of anidulafungin in the treatment of experimental Candida parapsilosis catheter infection using and antifungal-lock technique. Jounal of Antimicrobial Chemotherapy. In Press.

Date 1 Ma7 2016

Our recent laboratory publication. In this paper we study the role of each ribonucleotide reductase gene during Pseudomonas aeruginosa biofilm formation.

Crespo A, Pedraz L, Astola J and Torrents E (2016). Pseudomonas aeruginosa exhibits deficient biofilm formation in the absence of class II and III ribonucleotide reductases due to hindered anaerobic growth. Frontiers in Microbiology. 7:688.

Date 28 Abril 2015

New publications in our laboratory. In the Plos One we study the molecular basis of ribonucleotide reductase gene expression. In the Journal Controlled Release we explore the use of new PLGA nanoparticle to combat bacterial chronic bacterial infections.

- Baelo, A., Levato, R., Julián, E., Crespo, A., Astola, J., Gavaldà, J., Engel, E., Mateos-Timoneda, A., Torrents, E. (2015). Disassembling bacterial extracellular matrix with DNase-coated nanoparticles to enhance antibiotic delivery in biofilm infections. Journal Controlled Release. In Press.

- Crespo, A., Pedraz, L., Torrents, E. (2015). Function of the Pseudomonas aeruginosa NrdR Transcription Factor: Global Transcriptomic Analysis and Its Role on Ribonucleotide Reductase Gene Expression. PLoS ONE 10(4): e0123571.

Date 19-March 2015

New publication in PLoS One with the identification of a new molecule to combat bacterial infections.

Julián, E., Baelo, A., Gavaldà, J., Torrents, E. (2015). Methyl-Hydroxylamine as an Efficacious Antibacterial Agent That Targets the Ribonucleotide Reductase Enzyme. PLoS ONE 10(3): e0122049.

Press release at the IBEC web page.

Date: 21-January 2015

New publication in Infection and Immunity descriving the role of the ribonucleotide reductase NrdR and NrdDG in Escherichia coli LF82 infection.

Dreux, N., Cendra, MM., Massier, S., Darfeuille-Michaud, A., Barnich, N., Torrents, E. (2015). Ribonucleotide reductase NrdR as a novel regulator for motility and chemotaxis during adherent-invasive Escherichia coli infection. Infection and Immunity. In Press.

Press release at the IBEC web page.